In this interview with Philip Hajduk, VP of Information Research at AbbVie and Mark Ferneau from MarkLogic, they discuss how AbbVie is speeding the development of new innovations in drug development using MarkLogic to aggregate that data in context in an enterprise-grade system. The platform is now being used for things like Real World Evidence that couldn’t be done before. This interview took place at MarkLogic World 2018, which took place in downtown San Francisco, CA on May 7-10, 2018.

This website uses cookies.

By continuing to use this website you are giving consent to cookies being used in accordance with the MarkLogic Privacy Statement.